These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 27235659)

  • 1. [Esomeprazole-induced resistance to fluindione: An unrecognized interaction].
    Ayme-Dietrich E; Aubertin-Kirch G; Andrès E; Monassier L
    Therapie; 2016 Jun; 71(3):337-41. PubMed ID: 27235659
    [No Abstract]   [Full Text] [Related]  

  • 2. Esomeprazole: in gastroesophageal reflux disease in children and adolescents.
    Croxtall JD; Perry CM; Keating GM
    Paediatr Drugs; 2008; 10(3):199-205. PubMed ID: 18454572
    [No Abstract]   [Full Text] [Related]  

  • 3. Can colchicine potentiate the anticoagulant effect of fluindione?
    Gras-Champel V; Ohlmann P; Polard E; Wiesel ML; Imbs JL; Andréjak M
    Eur J Clin Pharmacol; 2005 Aug; 61(7):555-6. PubMed ID: 16007421
    [No Abstract]   [Full Text] [Related]  

  • 4. Esomeprazole magnesium.
    Am J Health Syst Pharm; 2002 Jan; 59(2):127-9. PubMed ID: 11826566
    [No Abstract]   [Full Text] [Related]  

  • 5. Pharmacokinetic and pharmacodynamic variability of fluindione in octogenarians.
    Comets E; Diquet B; Legrain S; Huisse MG; Godon A; Bruhat C; Chauveheid MP; Delpierre S; Duval X; Berrut G; Verstuyft C; Aumont MC; Mentré F
    Clin Pharmacol Ther; 2012 May; 91(5):777-86. PubMed ID: 22472992
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modeling INR data to predict maintenance fluindione dosage.
    Comets E; Mentré F; Pousset F; Diquet B; Montalescot G; Ankri A; Mallet A; Lechat P
    Ther Drug Monit; 1998 Dec; 20(6):631-9. PubMed ID: 9853979
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Esomeprazole magnesium (Nexium).
    Baker DE
    Rev Gastroenterol Disord; 2001; 1(1):32-41. PubMed ID: 12120118
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Esomeprazole for the Treatment of Erosive Esophagitis in Children: An International, Multicenter, Randomized, Parallel-Group, Double-Blind (for Dose) Study.
    Tolia V; Youssef NN; Gilger MA; Traxler B; Illueca M
    J Pediatr Gastroenterol Nutr; 2015 Jul; 60 Suppl 1():S24-30. PubMed ID: 26422095
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of pantoprazole 20 mg daily compared with esomeprazole 20 mg daily in the maintenance of healed gastroesophageal reflux disease: a randomized, double-blind comparative trial - the EMANCIPATE study.
    Goh KL; Benamouzig R; Sander P; Schwan T;
    Eur J Gastroenterol Hepatol; 2007 Mar; 19(3):205-11. PubMed ID: 17301646
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Long-term treatment of patients with symptomatic gastroesophageal reflux disease comparing costs and efficacy over 6 months of treatment with Nexium On-Demand Treatment or Nexium continuous treatment. An open, randomised multi-center study].
    Beglinger C; Thalmann C; Szucs T; Michetti P
    Praxis (Bern 1994); 2006 Mar; 95(13):483-7. PubMed ID: 16602668
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beraprost sodium-fluindione combination in healthy subjects: pharmacokinetic and pharmacodynamic aspects.
    Warot D; Berlin I; Aymard G; Ankri A; Fabry C; Besse B; Lechat P; Diquet B
    Fundam Clin Pharmacol; 2000; 14(3):231-6. PubMed ID: 15602800
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The efficacy, safety and cost-effectiveness of hydrotalcite versus esomeprazole in on-demand therapy of NERD: A multicenter, randomized, open-label study in China.
    Xiao YL; Nie YQ; Hou XH; Xie PY; Fang JY; Yuan YZ; Zhou LY; Zhao NQ; Chen MH
    J Dig Dis; 2013 Sep; 14(9):463-8. PubMed ID: 23659834
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Population pharmacokinetic-pharmacodynamic analysis of fluindione in patients.
    Mentré F; Pousset F; Comets E; Plaud B; Diquet B; Montalescot G; Ankri A; Mallet A; Lechat P
    Clin Pharmacol Ther; 1998 Jan; 63(1):64-78. PubMed ID: 9465843
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the pharmacokinetic interaction between esomeprazole (40 mg) and acetylsalicylic acid (325 mg) in healthy volunteers.
    Niazi M; Andersson T; Nauclér E; Sundin M; Naesdal J
    Int J Clin Pharmacol Ther; 2009 Sep; 47(9):564-9. PubMed ID: 19761715
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Esomeprazole for the Treatment of Erosive Esophagitis in Children: An International, Multicenter, Randomized, Parallel-Group, Double-Blind (for Dose) Study.
    Tolia V; Youssef NN; Gilger MA; Traxler B; Illueca M
    J Pediatr Gastroenterol Nutr; 2015 Jul; 60 Suppl 1():S24-30. PubMed ID: 26121347
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cytolytic hepatitis and esomeprazole during chemotherapy].
    Capitain O; Lortholary A; Abadie-Lacourtoisie S
    Presse Med; 2005 Oct; 34(17):1235-6. PubMed ID: 16230965
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Esomeprazole-induced photoallergic dermatitis.
    Shukla A; Mahapatra A; Gogtay N; Khopkar U
    J Postgrad Med; 2010; 56(3):229-31. PubMed ID: 20739778
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictors of heartburn resolution and erosive esophagitis in patients with GERD.
    Orlando RC; Monyak JT; Silberg DG
    Curr Med Res Opin; 2009 Sep; 25(9):2091-102. PubMed ID: 19601705
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Garlic interaction with fluindione: a case report.
    Pathak A; Léger P; Bagheri H; Senard JM; Boccalon H; Montastruc JL
    Therapie; 2003; 58(4):380-1. PubMed ID: 14679681
    [No Abstract]   [Full Text] [Related]  

  • 20. Healing of Erosive Esophagitis and Improvement of Symptoms of Gastroesophageal Reflux Disease After Esomeprazole Treatment in Children 12 to 36 Months Old.
    Tolia V; Gilger MA; Barker PN; Illueca M
    J Pediatr Gastroenterol Nutr; 2015 Jul; 60 Suppl 1():S31-6. PubMed ID: 26422096
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.